Physician profile
Larry Johnson
NPI 1053410662
$55,422.13
in general payments reported to CMS, 2019-2025
15 companies · $1,645 in 2025
The $1,645 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $14K · 2021: $16K · 2022: $698 · 2023: $194 · 2024: $2,363 · 2025: $1,645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,818 · Food and Beverage: $1,383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,818.33 |
| Food and Beverage | $1,383.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $54,905.16 | 2019-2025 | Journey II, Journey, Ri Hip Navigation |
| Pacira Therapeutics, INC. | $108.90 | 2019-2021 | |
| Gentleman Orthopedic Solutions | $74.83 | 2020 | |
| Zimmer Biomet Holdings, INC. | $71.33 | 2024 | |
| Orthofix Medical, INC. | $38.13 | 2019-2023 | Physio-Stim |
| Convatec INC. | $34.77 | 2022 | |
| Amgen INC. | $31.47 | 2019 | |
| Avanos Medical | $26.71 | 2023 | Trivisc Sodium Hyaluronate |
| Kowa Pharmaceuticals America, INC. | $25.57 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $22.78 | 2019 | |
| Depuy Synthes Sales INC. | $19.69 | 2023 | Monovisc, Orthovisc |
| Boston Scientific Corporation | $18.93 | 2022 | |
| Davol INC. | $17.53 | 2025 | Arista |
| Sanara Medtech INC. | $15.10 | 2025 | Celleraterx |
| Heraeus Medical, LLC. | $11.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.